19 Jun 2024 --- US-based Mindbloom, a provider of psychedelic medicine, designed the ketamine therapy with the preparation, integration and in-session content of a leading trauma therapist for people recovering from post-traumatic stress disorder (PTSD). According to the company, this condition affects 13 million people in the US each year. The program uses therapy protocols featuring ketamine psychedelics that have recently demonstrated effectiveness and safety in the most extensive peer-reviewed study “in the history of ketamine therapy and psychedelic medicine.”
